Carcinoid Tumor
📧 Sign up to get email alerts when something new happens for Carcinoid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. [Phase 1]
This is a Phase 1 clinical trial update for RayzeBio's RYZ401 in subjects with solid tumors expressing somatostatin receptors; the study is …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy [Phase 3]
Phase 3 trial update for RYZ101 versus standard of care in patients with inoperable, well-differentiated SSTR-positive gastroenteropancreati…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Natural History of Familial Carcinoid Tumor
This article notes a clinical trial investigating the natural history of familial carcinoid tumors, with the study currently recruiting part…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors [Phase 2]
This Phase 2 trial investigates the combination of lenvatinib and everolimus in patients with advanced, unresectable carcinoid tumors and re…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors [EARLY_Phase 1]
This early-phase trial investigates a dual-energy CT scan to detect gastrointestinal carcinoid tumors, with status currently active but not …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors [NA]
This clinical trial update reports on the diagnostic performance of urine and plasma 5-HIAA in patients with small intestine neuroendocrine …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors [Phase 2]
This Phase 2 clinical trial update reports recruitment for an alternative cabozantinib dosing schedule in metastatic renal cell carcinoma an…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
RegisterNET is a registry for neuroendocrine tumors in the USA and worldwide. It is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome [Phase 2]
Phase 2 study of paltusotine in patients with carcinoid syndrome completed with results posted, detailing safety, pharmacokinetics, and dose…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers [Phase 2]
A national platform coordinating five Phase II academic trials at Lyon to assess the safety and efficacy of the domvanalimab + zimberelimab …
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: ALG-LungCancerRegistry (SAFRO2202)
An ongoing clinical trial registry in Algeria (SAFRO2202) for lung cancer is recruiting patients with non-small cell lung cancer, small cell…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Cabozantinib and Nivolumab for Carcinoid Tumors [Phase 2]
A Phase 2 study evaluating the combination of cabozantinib and nivolumab for carcinoid tumors has completed with results posted in January 2…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in patients with advanced pancreatic neuroendocrine tumors and carcinoid tumors; results have been pos…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in advanced pancreatic neuroendocrine and carcinoid tumors; ACTIVE_NOT_RECRUITING with results posted …
-
CLINICAL_TRIALS other · 2024-08-21Clinical Trial Update: Personalized PRRT of Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update for personalized peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors, currently active but n…
-
FDA approval · 2024-07-01FDA Approved: KIT FOR THE PREPARATION OF INDIUM IN 111 PENTETREOTIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a kit for the preparation of Indium-111 pentetreotide used in imaging neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
This clinical trial update reports the completion of studies examining biomarkers of angiogenesis in renal cell carcinoma and neuroendocrine…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors [Phase 2]
A Phase II study evaluated ramucirumab with a somatostatin analog in patients with advanced, progressive carcinoid tumors. The trial has com…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating nivolumab with ipilimumab in neuroendocrine tumors (including carcinoid) has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 2]
Phase 2 clinical trial update for cabozantinib in advanced pancreatic neuroendocrine tumors and carcinoid tumors has completed with results …
-
FDA approval · 2023-06-30FDA Approved: OCTREOTIDE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for octreotide acetate filed by Fresenius Kabi USA, LLC.
-
EMA withdrawal · 2022-12-15EMA Withdrawn: IntronA (interferon alfa-2b) — Merck Sharp & Dohme B.V.
The European Medicines Agency has withdrawn IntronA (interferon alfa-2b) from the market.
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors [Phase 2]
Phase 2 clinical trial update for Ziv-Aflibercept in advanced progressive carcinoid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating nintedanib in locally advanced or metastatic neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) [Phase 2]
Phase 2 trial evaluation of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid tumors has compl…